Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway
Clinical pathology of Werner syndrome starting from 10 to 20 years of age including early graying, short stature, hair loss, and bilateral cataracts
Primary Research Areas NNMT enzymology and pharmacology the lead first-in-class selective small-molecule NNMT inhibitor used to validate the entire target class [1,2]
Coming Soon Memberships Recurring treatments, monthly scans, and preferred pricing built into your routine
Are there side effects to taking these supplements
As of 2026, we're seeing an increased interest in optimizing delivery systems, particularly exploring innovative transdermal technologies that could enhance the peptide's penetration and efficacy